BiotechTube
Home/Ascentage Pharma Group/Dr. Dajun Yang
DD

Dr. Dajun Yang

Founder, Chairman, and CEO

Ascentage Pharma Group

Therapeutic Areas

OncologyVirology

Ascentage Pharma Group Pipeline

DrugIndicationPhase
APG-2575 (Lisaftoclax)Relapsed/Refractory CLL/SLLPhase 3
APG-115 (Alrizomadlin)Metastatic MelanomaPhase 2
APG-2449ALK+ NSCLCPhase 1/2
APG-1387Chronic Hepatitis BPhase 2
APG-1252 (Pelcitoclax)Small Cell Lung CancerPhase 1/2
APG-5918Advanced Solid Tumors & LymphomasPhase 1
APG-3785Advanced Solid TumorsPreclinical

Leadership Team at Ascentage Pharma Group

DY
Dr. Yifan Zhai
Chief Medical Officer
DG
Dr. Guoqing Cao
Senior Vice President, Head of Biology
View full Ascentage Pharma Group profile